Anticholinergics, a class of drugs used for conditions including allergies, colds, high blood pressure and depression, may be associated with an increased risk of developing mild thinking and memory problems, particularly in people who have genetic risk factors for Alzheimer's disease or markers of this condition, according to a new study.
Patient Charities In UK Failing To Report Multimillion Donations From Pharma Industry